We are live on ! Find out more
ANIP icon

ANI Pharmaceuticals
ANIP

196 hedge funds and large institutions have $704M invested in ANI Pharmaceuticals in 2019 Q2 according to their latest regulatory filings, with 21 funds opening new positions, 82 increasing their positions, 51 reducing their positions, and 13 closing their positions.

New
Increased
Maintained
Reduced
Closed

62% more first-time investments, than exits

New positions opened: 21 | Existing positions closed: 13

61% more repeat investments, than reductions

Existing positions increased: 82 | Existing positions reduced: 51

30% more capital invested

Capital invested by funds: $543M → $704M (+$161M)

16% more call options, than puts

Call options by funds: $7.06M | Put options by funds: $6.07M

6.23% more ownership

Funds ownership: 65% → 71.23% (+6.2%)

3% more funds holding

Funds holding: 190 → 196 (+6)

0% more funds holding in top 10

Funds holding in top 10: 2 → 2 (0)

Holders
196
Holders Change
+6
Holders Change %
+3.16%
% of All Funds
4.26%
Holding in Top 10
2
Holding in Top 10 Change
–
Holding in Top 10 Change %
–
% of All Funds
0.04%
New
21
Increased
82
Reduced
51
Closed
13
Calls
$7.06M
Puts
$6.07M
Net Calls
+$997K
Net Calls Change
-$2.6M

Top Buyers

1
Invesco
Invesco
Georgia
+$8.11M
2
Deutsche Bank
Deutsche Bank
Germany
+$6.89M
3
Nomura Holdings
Nomura Holdings
Japan
+$6.79M
4
Renaissance Technologies
Renaissance Technologies
New York
+$6.32M
5
N
Nuveen
North Carolina
+$6.12M

Top Sellers

1
SG Americas Securities
SG Americas Securities
New York
-$4.21M
2
WAM
Weiss Asset Management
Massachusetts
-$2.31M
3
Charles Schwab
Charles Schwab
California
-$1.51M
4
CCM
Cadence Capital Management
Massachusetts
-$1.45M
5
PAM
Panagora Asset Management
Massachusetts
-$1.16M
Name Holding Trade Value Shares
Change 		Change in
Stake
AIM
176
Advantage Investment Management
Iowa
$11K – – –
FMII
177
Farmers & Merchants Investments Inc
Nebraska
$11K – – –
CTC
178
Central Trust Company
Missouri
$9K -$1.42K -20 -15%
Federated Hermes
179
Federated Hermes
Pennsylvania
$8K +$6.54K +92 New
QT
180
Quantbot Technologies
New York
$8K +$7.11K +100 New
Daiwa Securities Group
181
Daiwa Securities Group
Japan
$6K +$853 +12 +19%
PCP
182
Proficio Capital Partners
Massachusetts
$4K +$2.63K +37 +231%
CFGS
183
Concourse Financial Group Securities
Alabama
$3K – – –
ClearBridge Investments
184
ClearBridge Investments
New York
$2K – – –
SIAS
185
Shine Investment Advisory Services
Colorado
$2K – – –
TFGT
186
TS Financial Group (TSFG)
Illinois
$2K – – –
RCAG
187
Rehmann Capital Advisory Group
Michigan
$1.97K – – –
MUAMU
188
Mitsubishi UFJ Asset Management (UK)
United Kingdom
$1.07K +$925K +13,000 New
CAPTRUST Financial Advisors
189
CAPTRUST Financial Advisors
North Carolina
$1K – – –
HGWM
190
Harvest Group Wealth Management
Massachusetts
$1K – – –
TWA
191
TCI Wealth Advisors
Arizona
$1K – – –
PFBT
192
Parkside Financial Bank & Trust
Missouri
$1K +$356 +5 +83%
GT
193
Glenmede Trust
Pennsylvania
$2 – – –
Marshall Wace
194
Marshall Wace
United Kingdom
– -$797K -11,303 Closed
Millennium Management
195
Millennium Management
New York
– -$500K -7,085 Closed
PP
196
Paloma Partners
Connecticut
– -$294K -4,164 Closed
ECM
197
Element Capital Management
New York
– -$271K -3,841 Closed
Cambridge Investment Research Advisors
198
Cambridge Investment Research Advisors
Iowa
– -$212K -3,000 Closed
BWM
199
BerganKDV Wealth Management
Minnesota
– -$141K -2,000 Closed
QT
200
Quantamental Technologies
New York
– -$61K -862 Closed
5 6 7
8
9

ANIP Hedge Fund Activity: Q2 2019 in Review

196 of the 4,604 institutional investors tracked by Wall St. Rank reported a position in ANI Pharmaceuticals (ANIP) for Q2 2019, worth a combined $704M — up 30% from $543M a quarter earlier.

Buyers outnumbered sellers: 21 funds opened new ANIP positions and 13 closed out — a net gain of 8 holders — while 82 added to existing stakes and 51 trimmed.

The largest buyer was Invesco, adding an estimated $8.11M. The largest seller was SG Americas Securities, cutting an estimated $4.21M.

  • 196 institutional investors held ANI Pharmaceuticals (ANIP) as of Q2 2019, up from 190 in Q1 2019.
  • Funds reported $704M of ANI Pharmaceuticals stock for Q2 2019, up 30% quarter-over-quarter.
  • 21 funds opened new ANI Pharmaceuticals positions in Q2 2019 and 13 closed out, a net change of +8 holders.
  • The largest ANI Pharmaceuticals buyer in Q2 2019 was Invesco, an estimated $8.11M added.
  • The largest ANI Pharmaceuticals seller in Q2 2019 was SG Americas Securities, an estimated $4.21M sold.

Based on aggregated 13F filings for Q2 2019.